ING Group’s Pacific Biosciences PACB Stock Holding History

Quarter	Market Value	Status	Shares	Shares Change %	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-117,806	Closed	-$637K	–	801
2018 Q3	$637K	Sell	117,806 -90,196	-43%	-$488K	0.01%	457
2018 Q2	$738K	Buy	208,002 +5	+0%	+$18	0.01%	385
2018 Q1	$426K	Hold	207,997	–	–	0.01%	513
2017 Q4	$549K	Buy	+207,997	New	+$549K	0.01%	478
2016 Q4	–	Sell	-43,500	Closed	-$384K	–	588
2016 Q3	$384K	Sell	43,500 -32,520	-43%	-$287K	﹤0.01%	462
2016 Q2	$535K	Sell	76,020 -70,980	-48%	-$500K	0.01%	329
2016 Q1	$1.25M	Sell	147,000 -62,374	-30%	-$531K	0.02%	269
2015 Q4	$2.75M	Sell	209,374 -40,626	-16%	-$533K	0.02%	381
2015 Q3	$913K	Hold	250,000	–	–	0.01%	449
2015 Q2	$1.44M	Hold	250,000	–	–	0.01%	474
2015 Q1	$1.46M	Hold	250,000	–	–	0.01%	548
2014 Q4	$1.96M	Buy	+250,000	New	+$1.96M	0.01%	490
2014 Q3	–	Sell	-250,000	Closed	-$1.54M	–	667
2014 Q2	$1.54M	Hold	250,000	–	–	0.01%	488
2014 Q1	$1.34M	Hold	250,000	–	–	0.01%	530
2013 Q4	$1.31M	Buy	+250,000	New	+$1.31M	0.01%	528